You are here
HPV vaccination not linked to multiple sclerosis
The Lancet Oncology, Volume 16, Issue 2, February 2015, Pages e57
HPV vaccination is not associated with an increased risk of multiple sclerosis (MS) or other demyelinating diseases, a study of almost 4 million people has confirmed. The media has previously reported on suspected cases of MS occurring after HPV vaccination, and there has also been an increase in the number of case reports describing symptoms of MS in vaccine recipients. For this latest study, researchers used nationwide registers to examine data on HPV vaccination and on incident diagnoses of MS and other demyelinating diseases in Danish and Swedish girls and women aged between 10 and 44 years, from 2006 to 2013.